The past year has been brutal for three stocks sitting at their lowest points in 12 months, forcing investors to weigh whether they are seeing value opportunities or deteriorating fundamentals.
Chewy (NYSE: CHWY) has shed 22% over the past month alone, making it one of the more dramatic decliners in the consumer internet space during that period.
Founded by Ryan Cohen, who later became widely known for his involvement in GameStop (NYSE: GME), Chewy built its business as an online retailer specializing in pet food, supplies, and healthcare services.
The company’s revenue has grown at just 6.5% annually over the last three years, a pace that trails most comparable consumer internet businesses by a meaningful margin.
Wall Street’s forward estimates suggest conditions are unlikely to improve dramatically, with analysts projecting tepid revenue growth of only 7% over the next 12 months.
A gross margin of 29.7% leaves Chewy with less capital to reinvest in critical growth areas such as marketing and research and development compared to stronger competitors.
At a stock price of $18.15, Chewy trades at 8.2x forward EV/EBITDA, a valuation that reflects the market’s skepticism about the company’s near-term growth trajectory.
Bark (NYSE: BARK), best known for its subscription-based BarkBox product, presents a similarly concerning picture, with shares down 16% over the past month and trading at $8.15 per share.
The company’s sales have declined at a rate of 2.5% annually over the last five years, a trend that signals consumer appetite for its personalized pet product subscriptions may be softening.
Bark’s cash-burning tendencies raise questions about its ability to generate sustainable shareholder value, and a depletion of cash reserves could eventually force a fundraising event that dilutes existing shareholders.
BWX Technologies (NYSE: BWXT), by contrast, stands out as the one name among the three that analysts view as a genuine buying opportunity despite an 8.6% decline over the past month.
BWX has roots stretching back to the Manhattan Project in the 1940s and today manufactures nuclear components and fuel for both government and commercial industries.
The company has posted annual revenue growth of 16.2% over the last two years, a rate that reflects meaningful market share gains in a sector with high barriers to entry.
Projected revenue growth of 14.3% over the next 12 months further reinforces the bullish case, suggesting the company is continuing to expand its footprint in nuclear services.
Free cash flow margin has expanded by 6.1 percentage points over the last five years, giving BWX greater financial flexibility to pursue investments, share buybacks, and dividend distributions.
At $146.66 per share and trading at 27.2x forward price-to-earnings, BWX carries a premium valuation that appears increasingly justified by its consistent execution and strong forward momentum.
